Immunology News and Research

Latest Immunology News and Research

Scientists look to use natural killer cells to target common form of liver cancer

Scientists at the University of Southampton are to investigate the best way to use natural killer cells (NK) to target the most common form of liver cancer. NK cells are able to directly kill cancer in the body and stimulate other cells in the immune system to help attack cancer.

14 Oct 2012

Researchers develop interference therapies to knock down gene that drives MCL

Three thousand new cases of Mantle Cell Lymphoma (MCL), a form of blood cancer, appear in the United States each year. With a median survival span of only five to seven years, according to the Leukemia and Lymphoma Society, this disease is devastating, and new therapies are sorely needed.

From Integrated DNA Technologies 11 Oct 2012

Study finds how MAIT cells recognize products of vitamin B synthesis from bacteria and yeast

An Australian research team has discovered how specialised immune cells recognise products of vitamin B synthesis that are unique to bacteria and yeast, triggering the body to fight infection.

11 Oct 2012

UCSF project to explore mystery behind advanced prostate cancer

Many men survive prostate cancer, but thousands of others -- whose cancer spreads -- inevitably develop resistance to even the most promising treatments, leaving them with few medical options and a dwindling span of life.

10 Oct 2012

U-M researchers to better understand HIV virus on a molecular level

A new $21-million grant will help researchers at the University of Michigan Health System better understand the HIV virus on a molecular level, potentially paving the way for new treatment approaches to AIDS and other diseases.

10 Oct 2012

Roitt's Essential Immunology receives BMA Book of the Year Award

John Wiley & Sons, Inc., today announced that Roitt's Essential Immunology, 12th Edition, has won the prestigious British Medical Association (BMA) Book of the Year Award.

10 Oct 2012

Chemotherapy plus immunotherapy can enhance anti-tumor effects in patients with advanced cancer

Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and Tianjin Medical University Cancer Institute and Hospital in China have discovered that combining chemotherapy drugs and immunotherapy cancer vaccines results in an enhanced anti-tumor effect.

10 Oct 2012

Recovering Treg cells in pancreatic lymph nodes may restore insulin production in type I diabetics

The key to restoring production of insulin in type I diabetic patients, previously known as juvenile diabetes, may be in recovering the population of protective cells known T regulatory cells in the lymph nodes at the "gates" of the pancreas, a new preclinical study published online October 8 in Cellular & Molecular Immunology by researchers in the Department of Bioscience Technologies at Thomas Jefferson University suggests.

10 Oct 2012

Researchers discover mechanism by which magnesium reduces cytokine production

Magnesium sulfate is given to many pregnant women to treat preterm labor and preeclampsia and was recently shown to prevent cerebral palsy; however little is known about how it works. Researchers at Case Western Reserve University School of Medicine recently discovered the mechanism by which magnesium reduces the production of cytokines.

10 Oct 2012

Harvard announces ExxonMobil Malaria Scholar in Residence

The Harvard School of Public Health announced on Thursday that Regina Rabinovich, former director of infectious diseases at the Bill & Melinda Gates Foundation, has been chosen to be the ExxonMobil Malaria Scholar in Residence, "where she will focus on innovative strategies to combat malaria," according to a Harvard press release.

8 Oct 2012

ImaginAb enters into neurodegeneration research collaboration agreement with Lundbeck

ImaginAb, Inc., a clinical-stage company developing in vivo molecular imaging agents based on antibody fragment technology, today announced that it has entered into a collaboration and commercialization agreement with H. Lundbeck A/S.

8 Oct 2012

CytoDyn announces update on feline immunodeficiency virus therapeutic antibody program

CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced today that it is presenting an update on its Feline Immunodeficiency Virus (FIV) therapeutic antibody program at the 19th West Coast Retrovirus meeting in Palm Springs, California.

8 Oct 2012

Tips to differentiate between children's cold and allergies

One of the problems that parents may have during the fall is deciphering whether their children's sneezing is due to a cold or allergies.

6 Oct 2012

Pesticide exposure may trigger food allergies

Results from the US National Health and Nutrition Examination Survey suggest that high exposure to dichlorophenols, chemicals found in pesticides and used for chlorinating water, may increase a person’s risk for developing food allergies.

5 Oct 2012

Article explores safety and efficacy of aerosol delivery of drugs in ICU patients

Essential medications can be delivered as inhaled drugs to critically ill patients in the Intensive Care Unit (ICU) who require mechanical ventilation to breathe. Aerosol drug delivery is highly complex, however, and if not done properly the medication will not reach the lungs and therapy will be ineffective.

5 Oct 2012

Sublingual immunotherapy highly effective for chronic allergy and asthma sufferers

Could it be that those with allergic rhinitis (hay fever) and childhood nasal allergies can finally get a break from their allergies and their allergy shots? Chicago's leading allergy, asthma, and immunology expert, Dr. Brian Rotskoff, who treats a large number of Chicago pediatric allergy patients, is happy to say, "Yes!"

5 Oct 2012

Seasonal allergies more prevalent in Louisville, KY

The Asthma and Allergy Foundation of America (AAFA) recently announced its 2012 Fall Allergy Capitals with Louisville, KY coming in at No. 1. Other cities topped the previous year's rankings, with Baton Rouge, LA climbing 13 spots to the No.10 position.

4 Oct 2012

Circassia commences ToleroMune phase 3 trial in cat allergen-induced rhinoconjunctivitis

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the start of a pivotal phase 3 trial of its investigational ToleroMune cat allergy treatment for cat allergen-induced rhinoconjunctivitis.

4 Oct 2012

Study investigates time-dependent efficacy of hUCB MNCs after experimental brain ischemia

A research team from Germany has found that optimal benefit and functional improvement for ischemic stroke results when human umbilical cord blood mononuclear cells (hUCB MNCs) are transplanted into rat stroke models within 72 hours of the stroke.

3 Oct 2012

GW researcher to help HIV patients better understand treatments for cardiovascular issues

In 1980, men and women who were diagnosed with the human immunodeficiency virus (HIV) had little to no hope of living long, full lives. Thanks to advances in science and medicine, this is no longer the case. HIV patients now live a near-normal lifespan. However, as patients live longer, new medical issues arise.

3 Oct 2012

Immunology News and Research

Latest Immunology News and Research

Scientists look to use natural killer cells to target common form of liver cancer

Researchers develop interference therapies to knock down gene that drives MCL

Study finds how MAIT cells recognize products of vitamin B synthesis from bacteria and yeast

UCSF project to explore mystery behind advanced prostate cancer

U-M researchers to better understand HIV virus on a molecular level

Roitt's Essential Immunology receives BMA Book of the Year Award

Chemotherapy plus immunotherapy can enhance anti-tumor effects in patients with advanced cancer

Recovering Treg cells in pancreatic lymph nodes may restore insulin production in type I diabetics

Researchers discover mechanism by which magnesium reduces cytokine production

Harvard announces ExxonMobil Malaria Scholar in Residence

ImaginAb enters into neurodegeneration research collaboration agreement with Lundbeck

CytoDyn announces update on feline immunodeficiency virus therapeutic antibody program

Tips to differentiate between children's cold and allergies

Pesticide exposure may trigger food allergies

Article explores safety and efficacy of aerosol delivery of drugs in ICU patients

Sublingual immunotherapy highly effective for chronic allergy and asthma sufferers

Seasonal allergies more prevalent in Louisville, KY

Circassia commences ToleroMune phase 3 trial in cat allergen-induced rhinoconjunctivitis

Study investigates time-dependent efficacy of hUCB MNCs after experimental brain ischemia

GW researcher to help HIV patients better understand treatments for cardiovascular issues

Immunology eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring